IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 7, 2017, Pages 2129-2131

  Hopkins, Katie L ^a   Findlay, Jacqueline ^a   Doumith, Michel ^a   Mather, Barry ^b   Meunier, Daniéle ^a   D'Arcy, Stuart ^c   Pike, Rachel ^a   Mustafa, Nazim ^a   Howe, Robin ^b   Wootton, Mandy ^b   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMI 2 CARBAPENEMASE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TEMOCILLIN; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHEMICAL ANALYZER; INTENSIVE CARE UNIT; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA VARIICOLA; MASS SPECTROMETER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; SOFT TISSUE INFECTION; TEST STRIP; UNITED KINGDOM; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HORIZONTAL GENE TRANSFER; HUMAN; ISOLATION AND PURIFICATION; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CARBAPENEMS; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; GENE TRANSFER, HORIZONTAL; HUMANS; IMIPENEM; KLEBSIELLA; PLASMIDS; THIENAMYCINS; UNITED KINGDOM;

EID: 85021809239     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkx103     Document Type: Article

References (10)

1. Rasmussen BA, Bush K, Keeney D et al. Characterization of IMI-1 b-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob Agents Chemother 1996; 40: 2080-6.
2. Naas T, Dortet L, Iorga BI. Structural and functional aspects of class A carbapenemases. Curr Drug Targets 2016; 17: 1006-28.
3. Di Luca MC, SkaareD, Aasnaes B et al. Identification of a novel IMI carbapenemase variant (IMI-9) in Enterobacter cloacae complex. Int J Antimicrob Agents 2016; 48: 764-5.
4. Aubron C, Poirel L, Ash RJ et al. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg Infect Dis 2005; 11: 260-4.
5. Dang B, Mao D, Luo Y. Complete nucleotide sequence of pGA45, a 140,698-bp IncFIIY plasmid encoding blaIMI-3-mediated carbapenem resistance, fromriver sediment. FrontMicrobiol 2016; 7: 188.
6. IMI-2 gene in a clinical Escherichia coli strain. Antimicrob Agents Chemother 2012; 56: 1146-7.
7. Doumith M, Day M, Ciesielczuk H et al. Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J ClinMicrobiol 2015; 53: 160-6.
8. Rosenblueth M, Martinez L, Silva J et al. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst Appl Microbiol 2004; 27: 27-35.
9. van Veen SQ, Claas EC, Kuijper EJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 2010; 48: 900-7.
10. Maatallah M, Vading M, Kabir MH et al. Klebsiella variicola is a frequent cause of bloodstream infection in the Stockholm area, and associated with higher mortality compared to K. pneumoniae. PLoS One 2014; 9: e113539.